Table 1.

Summary outcomes of analysis of cell type and treatment type, by group.

Outcome	Group	Mean (SD)	p-value
Decay time constant (days−1)	Control without TGF-β1	1.9 (0.5)	0.0707
	CTS patient without TGF-β1	2.6 (0.6)
	Control with TGF-β1	3.3 (0.8)	0.0052
	CTS patient with TGF-β1	5.1 (0.9)
Tensile strength (mN)	Control without TGF-β1	5.1 (0.8)	0.0059
	CTS patient without TGF-β1	7.0 (1.0)
	Control with TGF-β1	11.1 (1.5)	0.0282
	CTS patient with TGF-β1	13.0 (1.1)
Stiffness (mN/mm)	Control without TGF-β1	1.4 (0.4)	0.0580
	CTS patient without TGF-β1	1.8 (0.4)
	Control with TGF-β1	3.1 (0.6)	0.0027
	CTS patient with TGF-β1	4.5 (0.6)